The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo.
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening regulation on raw milk, more harshly scrutinizing the safety of vaccines, and cracking down on ultra-processed foods and additives.
A recall of products, including onions, from Gracie's Kitchen has been given a Class II risk classification from the FDA over fears of listeria monocytogenes contamination. The recall impacts almost 150 ready-to-eat fruit and vegetable products from the Connecticut based company, also including peppers and watermelons.
A Boston-based company has passed an important hurdle in its effort to get FDA approval for its ovarian-cancer treatment.
The proposed rule is required under a law passed by Congress last year, and is intended to ensure the safety of makeup and baby powder.
There was "low but improving uptake" of reporting about the diversity of participants in summary documents for FDA-cleared pulse oximeters after voluntary guidance was issued in 2013, an analysis of public FDA records found. Reports of race, ethnicity ...
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes.
Dichloromethane, a volatile solvent commonly used in industrial applications, has been banned in products in many areas, including the U.S. and the European Union, due to its potential health risks.
Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, although it is not a cure and requires weight loss to be maintained over
In early December, the Supreme Court heard oral argument in Food and Drug Administration v. Wages and White Lion Investments, a challenge to the FDA's
The FDA has announced a recall of a hair spray brand in 12 states after it was discovered that the product contains dichloromethane.